Risperdal Caused Autistic Boy's Breast Growth, Pa. Jury Told
By Matt Fair ( October 26, 2015, 4:19 PM EDT) -- A fourth trial in Pennsylvania state court over allegations that a Johnson & Johnson unit failed to provide adequate warnings about risks associated with the antipsychotic drug Risperdal got underway on Monday as a jury heard arguments that the medication caused an adolescent Maryland boy to grow breasts....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.